CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alseres Pharmaceuticals, Inc. (the Company) on Form 10-Q for the quarter ended June 30, 2013 as
filed with the Securities and Exchange Commission (the Report), I, Kenneth L. Rice, Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
/S/ KENNETH L. RICE, JR.
|Kenneth L. Rice, Jr.|
|Executive Vice President Finance and Administration and Chief Financial Officer|
Date: August 14, 2014